Integrin alpha9 emerges as a key therapeutic target to reduce metastasis in rhabdomyosarcoma and neuroblastoma.

Cell Mol Life Sci · 2022 · PMC9553833 · PMID 36221013

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

2014 [ 30 ] revealed a clear trend of integrin alpha chain overexpression in MYCN amplified tumours with significant overexpression of 14 alpha chains in MYCN-amplified tumours.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.